Abstract. Mutant V.24.1, a member of the End4 complementation group of temperature-sensitive CHO cells, is defective in secretion at the restrictive temperature
the same rate in mutant and parental cells at the restrictive temperature. Second, secretory proteins accumulated in a compartment intermediate between the ER and the Golgi. Several lines of evidence support this conclusion, the most direct being the colocalization by immunofluorescence microscopy of influenza virus hemagglutinin with a 58-kD protein that is known to reside in an intermediate compartment. Third, at the resolution of fluorescence microscopy, the Golgi complex in the mutant cells vanished at the restrictive temperature.
ECR~a'ORV material in mammalian cells first enters transport vesicles in the ER. Recent evidence suggests that material is delivered next to a compartment intermediate between the ER and the Golgi where proteins may then be either recycled back to the ER or pass on to the cisGolgi (3, 37, 43, 44, 49, 50) . Material then traverses the Golgi complex and finally enters the trans-Golgi network where contents are sorted and eventually delivered either to the plasma membrane or to lysosomes (for reviews see 2, 17, 38) . The general mechanism of membrane movement from one organelle to another during secretion is believed to be vesicular transport, which involves four main steps: (a) the sorting of proteins to be transported from those to be left behind; (b) vesicle formation; (c) vesicle targeting to the specific acceptor membrane; and (d) vesicle fusion with the acceptor membrane. The molecular mechanisms of some of these steps are just now beginning to emerge.
Major contributions to understanding secretory transport at the molecular level have been made by combining the genetic analysis of the secretory pathway in yeast (21, 32, 46) with the in vitro biochemical study of secretory transport in both mammalian cells (for example, see 2, 6, 58) and yeast (for example, see 1, 42, 51) . Progress in understanding secretion would also be advanced by isolating and analyzing secretion-defective mutants in animal cells. We previously isolated and studied a temperature-sensitive, conditionallethal mutant of CHO cells, termed V.24.1, that defined the End4 complementation group (7) and which had aberrant lysosomes at the restrictive temperature (8) . Subsequent studies demonstrated that V.24.1 cells were defective in secretion (39, 56) . In the present work, we used immunofluorescence microscopy and biochemical assays to demonstrate that the secretory block in the V.24.1 ceils prevents the export of material from a compartment that is intermediate between the ER and the Golgi. Interestingly, the block in secretion is correlated with the disappearance of the Golgi complex. A preliminary report of this work has appeared (Kao, C.-Y., P. A. Colbaugh, and R. K. Draper. 1990 . J. Cell Biol. 111:199a).
Materials and Methods

Reagents
TPCK-trypsin, soybean trypsin inhibitor, protein A-sepharose CL-4B, polyacrylamide, Tris base, MES, PMSF, aprotinin, sucrose, Triton X-100, nocodazole, NP-40, and bicinchoninic acid (BCA) protein assay reagent were purchased from Sigma Chemical Co. (St. Louis, MO). Endoglycosidase D (endo D) and endoglycosidase H (endo H) were from Boehringer Mannheim Biochernicals (Indianapolis, IN). Monensin was from Calbiochem (La Jolla, CA). AcrylAide was from FMC Corporation (Rockland, ME). Brefeldin A (BFA) was purchased from Epicentre Technologies (Madison, WI), dissolved at 1 mg/ml in ethanol, and stored at -70~ before use. Gamma.Bind G Agarose was from Genex Corporation (Galthersberg, MD). Entensify was from Du Pont-New England Nuclear (Boston, MA). Tran35S-label was from ICN Radiochemicals (Irvine, CA).
Folding of Influenza Virus HA
The extent of bemagglutinin (HA) folding within the ER was measured by its resistance to trypsin upon extraction from cells (9, 10) . Cells were seeded in 35-ram culture dishes for 1-2 d before the experiment. For virus infections at the restrictive temperature, cells were incubated at 41~ for 4 h, shifted to 39.5~ and medium containing virus was added. After 1 h, the medium was changed to remove free virus and the incuba~on was continned at 39.5~ for 4 h. Viral proteins were radiolabeled with Tran3SS-label for 5 win as described by Wang et el. (56) . At different times after the pulse, the cells were 1F-~d with 350 ~tl of iysis buffer (1% NP-40, 50 mM Tris, 150 mM NaCI, 10 mM EDTA, pH 8,0). The lysates were clarified by centrifugation in a Brinkman Microfuge for 10 rain and the protein concentration was determined by BCA assay (Sigma Chemical Co.). 75/~g of protein from each lysate were treated with 100/tg/ml of TPCK trypsin for 30 rain at 0~ Soybean trypsin inhibitor (final concentration I mg/ml) and aprotinin (0.1 TIU/mi) were added to stop the trypsin digestion. HA was immunoprecipitated with goat anti-HA antibody and GammaBindG Agarose. The immunoprecipitated proteins were then analyzed on 12% SDSpolyacrylamide gels (22) with AcrylAide as cross-linker. The gels were treated with Entensify, dried and exposed to preflashed (23) Kodak X-Omat AR film.
Trimerization of HA
The trimerization of HA within the ER was determined by the rate of HA sedimentation in sucrose gradients, as described by Copeland etal. (9) with minor modifications. Virus infection at the restrictive temperature and radiolabeling were as in the previous section. At times after radiolabeling, cells were lysed with 500/tl of 1% Triton X-100, 20 mM MES, 30 mM Tris, and 100 mM NaCI, pH 7.4, with protease inhibitors (1 mM PMSF, 0.1 TIU/mi aprotinin, and 100/tg/ml soybean trypsin inhibitor). The lysates were clarified by centrifugetion in a microfuge and layered on 5-25% (wt/vol) sucrose gradients in the lysis buffer without 1% Triton X-100. The gradients were centrifuged in a rotor (model SW41, Beckman Instruments, Inc., Palo Alto, CA) at 40,000 rpm for 16.5 h at 20~ After centrifugetion, 0.5-mi fractions were collected from the top of the tubes. HA was immunoprecipitared from alternate fractions and electrophoresed in 7.5 % SDS-polyacrylamide gels.
Endo H Digestion
Cells were grown on 35-ram plates for 1-2 d before the experiment. After virus infection and radiolabeling, as described in the legend to Fig. 1 , the cells were lysed for 20-30 rain on ice in 500 ~tl of lysis buffer containing protease inhihitors as described in the preceding paragraph. The lysatas were clarified by centrifugation in a Brinkman Micmfuge for 10 rain at 4~ and HA was immunoprecipitated with anti-HA antibodies and protein A-Sepharose. 30 t~l of 0.1% SDS in 50 mM sodium citrate, pH 5.5, was added to each sample and boiled for 5 min. Two 12-t~l aliquots were taken from each sample. One aliquot was mixed with 12 #1 of 50 mM citrate, pH 5.5 containing 0.2 mU endo H, and the other was mixed with citrate buffer only. Digestion was for 16 h at 37~ Laemmii sample buffer was added to stop the digestion and HA was electrophoresed in 7.5% SDSpolyacrylamide gels. Different forms of HA on the gel fluorographs were quantitated using a laser scanning densitometer (model 30OK; Molecular Dynamics, Sunnyvale, CA).
Endo D Digestion
Virus-infected cells were prepared and lysed as for endo H digestion except 350 #1 of lysis buffer was used. Two 100-#1 aliquots of each lysate were added to 100 #1 of 2.Sx digestion buffer (0.5 M sodium citrate, 6.25 mM EDTA, pH 6.35). 50/~1 of 10 mM Tris-HCl, pH 7.2, comaining 200 mM NaCI, either with or without 1 mU Endo D were then added. The tubes were tightly sealed and incubated at 37~ for 20 h. HA was immunoprecipitated and electrophoresed as for endo H digestion.
lmmunofluorescence Microscopy
Cells were grown on 12-ram round No. 1 glass coverslips for 2-3 d before an experiment. Except when staining for the p58 antigen, cells were rinsed twice with PBS containing 1 mM MgCIz and 0.1 mM CaCIz and incubated in methanol at -20~ for 5-10 min to simultaneously fix and permeahilize the cells. After the methanol treatmem, cells were rinsed with PBS and incubated with 1% BSA (in PBS) for 15 min to block nonspecific protein binding sites. Primary antibodies diluted in 1% BSA were added for 30 min at room temperature. The cells were then rinsed with 1% BSA three times during a 20-rain period to wash away unbound primary antibodies. The same incubation and washing procedures were used for fluorescent-labelad secondary antibodies. The cells were rinsed finally in double-distilled water and mounted in 4 ~1 of Mowiol (Polyscience Inc., Warrington, PA).
Cells stained for p58 were rinsed twice with PBS containing 1 mM MgCl2 and 0.1 mM CaClz, fixed with 3% paraformaldehyde (in PBS) for 15-20 rain at room temperature, the aldehyde was quenched with 50 mM NI-hCI for t0 rain, and cells were permeabilized with 0.05% Triton X-100 in NET/gel (150 mM NaC1, 5 mM EDTA, 50 mM Tris, pH 7.4, 0~)5% NP-40, 0.25% gelatin, 0.02% sodium azide) for 15 rain. The cells were then rinsed three times with NET/gel solution and incubated for 45 rain at room temperature with anti-p58 antiserum diluted 1:100 in NET/gel. After incubation with the antibody, the cells were washed with NET/gel five times during a 30-rain period with agitation, rinsed three times with PBS, and treated with methanol at -20~ for 5 rain. Staining for a second antigen, and adding secondary antibodies, was as described at the beginning of this section. Samples were viewed with a Zeiss photoscope equipped with epi-fluores. cence illumination and a 63 • Apochromat lens. Photography was with Kodak TMAX p3200 film (developed as EI 1,600) or Kodak TMAX 400 film. The bars shown on the prints represent 5 t~m.
Results
7Ime at the Restrictive Temperature Required to Block ER to Golgi Transport in V.24.I Cells
In V.24.1 cells, glycoproteins containing N-linked oligosaccharides do not acquire resistance to endo H at the restrictive temperature, evidence that transport from the ER to the Golgi is blocked (39, 56) . To see if this block was an early response to elevating the temperature, we measured the time at 41~ required to inhibit the acquisition of endo H resistance by HA. A summary of the procedure is diagrammed in Fig. I a: Cells were infected with influenza virus at 34~ shifted to 41~ for different times (AT), and labeled with Trans35S-label for 5 rain followed by a 30-min chase period. The sensitivity of HA to endo H was then determined (Fig. 1 b) . With wild-type cells, HA was almost completely resistant to endo H when cells were labeled immediately after raising the temperature to 41~ (AT = 0). This indicated that the 35 min used for the pulse and chase was sufficient time for HA to be transported from the ER to the Golgi or beyond. HA from the wild-type cells remained endo H resistant at AT = 4 h. With V.24.1 cells, only 62% of the HA Figure 1 . Time at 41~ required to block ER to Golgi transport in V.24.1 cells. A summary of the procedure is shown in A. Cells at 34~ were infected with influenza virus and the temperature was increased to 41~ Tranasslabel was added for 5 rain at different times after the temperature change, the radiolabel was removed, and the cells were incubated a further 30 rain in medium containing excess cold methionine and cysteine before they were lysed and HA was extracted. Endo H sensitivity was determined as described in Materials and Methods. The percentage of total HA that was endo H sensitive was measured by densitometric scan- 
Influenza Virus H A Remains Resistant to Digestion by Endo D in E24.1 Cells at the Restrictive Temperature
N-linked oligosaccharides of glycoproteins in the Mannose9 N-acetylglucosamine2 (Man9GlcNAc2) form within the ER are resistant to digestion by endo D. However, once in the Golgi the oligosaccharide chains are trimmed by a-l,2-mannosidase I to the Man5 GIcNAc2 species (4), which is sensitive to digestion by endo D (29, 52) . In addition, after oligosaccharide side chains acquire more GIcNAc by the action of N-acetylglucosamine transferase I, they are again resistant to endo D, and upon removal of more mannose by Golgi mannosidase II, they become resistant to endo H. Since HA did not become resistant to endo H, it was presumably not modified by N-acetylglucosamine transferase I and mannosidase II, but could have been present in the Man~GlcNAc2 form within the Golgi. If the HA were present in the MansGlcNAc2 form, it should be sensitive to digestion by endo D, and we assessed this possibility. As a positive control for the activity of endo D, the sensitivity of HA to endo D in the CHO 15B cell line, which fails to add GlcNAc to glycoproteins in the medial Golgi, was measured. In CHO its sensitivity to trypsin. Trypsin cleaves the initial form of properly folded HA (HA0, Mr = 78000) into HA1 (Mr = 55,000) and HA2 (Mr -" 27,000), whereas unfolded and misfolded HA is completely degraded. Cells were infected at the restrictive temperature with virus, radiolabeled, and lysed at the indicated times after radiolabeling as described in Materials and Methods. 75/zg of protein from each lysate was treated with TPCK-trypsin. Trypsin digestion was then stopped by the addition of soybean trypsin inhibitor. HA was immunoprecipitated with anti-HA antibodies, and electrophoresed in 12 % SDS-polyacrylamide gels. Radiolabeled proteins were detected by fluorography. 
Folding and Trimerization of HA Is Normal in V.24.1 Cells at the Restrictive Temperature
One explanation for the failure of glycoproteins to reach the Golgi in V.24.1 cells is that the lesion somehow impairs protein folding or oligomerization within the ER. It is welldocumented that the transport of proteins out of the ER to the Golgi apparatus requires proper folding and oligomerization (10, 16, 37) . To investigate the conformation of a secretory glycoprotein within the ER, we used established procedures (10, 16) to monitor the folding and trimerization of HA. Before folding, HA (referred to as HA0) is sensitive to digestion by trypsin but becomes resistant as it folds and trimerizes. Trypsinization of folded HA0 results in only two fragments, HA1 and HA2. To assess folding, mutant and parental cells were infected with influenza virus at the restrictive temperature and pulsed for 3 min with Tran35S-label. At times up to 15 min after the pulse, cells were lysed and extracts were incubated with trypsin. Trypsin inhibitor was added and immunoprecipitated HA was electrophoresed in SDS-polyacrylamide gels. Samples without trypsin treatment were included at times 0 and 15 min to assess the recovery of HA in the absence of trypsin (Fig. 3, lanes 1, 2 and  & 9 ). In the presence of trypsin, the recovery of HA1 and HA2 was very low at time 0, indicating that HA had not yet folded and was digested by trypsin (Fig. 3 , compare lane 1 with 3 and lane 8 with 10). Maximum recovery of HA1 and HA2 was observed by 10 rain after the pulse, revealing the acquisition of trypsin resistance that accompanies folding. There was no apparent difference between the mutant and parental cells in the rate at which HA became trypsin resistant.
HA trimerization in pulse-labeled cells was assessed by sedimenting cell lysates in sucrose gradients (9) . As shown in Fig. 4 , monomers of HA sedimented in fractions 6-8 of the gradients while trimers (centered around fraction 14) from the parental cells were observed within 5 rain of the chase and predominant by 10 rain of the chase period. There was no apparent difference in the rate of HA trimerization with the mutant cells (Fig. 4, right side) . Altogether, the data in Figs. 3 and 4 suggest that the secretory block in V.24.1 cells is not caused by a defect in the folding or oligomerization of proteins in the ER. Figure 4 . Rate of HA trimerization in wild-type and mutant cells at the restrictive temperature. Cells were incubated at the restrictive temperature, infected with influenza virus and radiolabeled as described in Materials and Methods. The cells were lysed at different times after radiolabeling as indicated on the left side of the figure. The monomeric and trimeric forms of HA were separated in 5-25 % sucrose gradients. HA was then immunoprecipitated from every other fraction collected from the gradients (fraction numbers are at the bottom of the figure), electrophoresed in 7.5 % SDS-polyacrylamide gels, and proteins were detected by fluorography.
FRACTION
HA Accumulates in a PostER Pre-Golgi Compartment
Considering that HA does not appear to reach the Golgi, it should either be retained within the ER itself or be transported as far as a compartment intermediate between the ER and the Golgi. To investigate this, we determined whether HA colocalized with a marker for the ER or with a marker for a post-ER compartment by immunofluorescence microscopy. The ER was identified using antibodies to BiP, a soluble protein located primarily within the ER (37) . The intermediate compartment was identified with antibody to p58, a 58-kD protein reported by Saraste and co-workers to reside in a reticular compartment intermediate between the ER and the cis-Golgi and in the cis-Golgi (44, 45) .
Wild-type and mutant cells were incubated at 41~ to initiate the lesion in the mutant cells and infected with influenza virus. The cells were then prepared for immunofluorescence microscopy to simultaneously visualize either HA and BiP (Fig. 5, a-d) , or HA and p58 (Fig. 5, e-h) . In wild-type cells, HA was predominantly in the Golgi and on the cell surface (Fig. 5, a and e) . In the mutant cells, HA appeared to be mainly in discrete vesicular structures concentrated in the nuclear area, but which were also present towards the cell periphery (Fig. 5, c and g ). The nuclear envelope in the mutant cells appeared to contain HA and HA also was observed in the ER. The morphology of the ER, shown by the staining for BiP, was similar in mutant and parental cells (Fig. 5, b Figure 5. Localization of HA, BiP, and p58 in mutant and wild-type cells infected with virus at the restrictive temperature. Cells grown on glass coverslips were incubated at 41~ for 2 h to elicit the temperature sensitive lesion, shifted to 39.5~ infected with virus, and fixed at4 h after infection. Cells were then incubated with goat anti-HA (a, c, e, g), and either rabbit anti-BiP (b and d) or rabbit anti-p58 (/and g) primary antibodies. Secondary antibodies were Texas red-labeled mouse anti-goat IgG and FITCqabeled mouse anti-rabbit IgG. and d), indicating that the ER was intact in V.24.1 cells (see also Fig. 7 d) . In wild-type cells, most of the p58 appeared to be within small vesicles concentrated primarily around the nucleus (Fig. 5 f ) . Most interesting, however, was the colocalization of p58 and HA in vesicles of the mutant cells (Fig. 5, g and h) . Considering that HA may not reach the cis- To see whether the transport of an endogenous cell protein, in addition to a viral glycoprotein, was arrested at the compartment defined by p58, we treated mutant and parental cells with BFA for I h at 34~ to redistribute Golgi proteins to the ER. The cells were then incubated for 2 h at 41~ to induce the lesion in the mutant cells and a control sample Figure 6 . A Oolgi protein induced to enter the ER by BFA accumulates in the intermediate compartment in V.24.1 cells upon removal of BFA at 41~ Cells grown on coverslips were treated with 5 t~g/ ml BFA at the permissive temperature for 1 h and then incubated for 2 h in the presence of the drug at 41~ BFA was then removed by extensive washing and the cells were either fixed immediately (a-d) or incubated for an additional 0.5 h at 41~ in the presence of cycloheximide before fixation (e-h). The cells were stained for double immunofluorescence using rat anti-gp125 and rabbit anti-p58 followed by FI-TC-conjugated donkey antirat IgG and Texas red-conjugated mouse anti-rabbit IgG.
of each cell type was fixed at this time. The remaining cells were washed to remove BFA and incubation at 41~ was continued for 0.5 h to allow transport of Golgi proteins in the ER back to the Golgi. Cells were then prepared for double immunofluorescence staining to simultaneously detect p58 and gp125, an integral membrane protein associated with the cis/medial-Golgi (Fig. 6 ). In the presence of BFA, a coherent perinuclear Golgi complex was not evident in either wildtype (Fig. 6 a) or mutant cells (Fig. 6 c) as expected. The intermediate compartment defined by p58 was present in both cell types in the presence of the drug (Fig. 6, b and d) , consistent with observations by Lippincott-Schwartz et al. (25) that the intermediate compartment persists in the presence of BFA. When BFA was removed and the cells were incubated at the restrictive temperature for an additional half hour, the Golgi complex reassembled in the wild-type cells (Fig. 6 e) but not in the V.24.1 cells (Fig. 6 g ). In the mutant cells, gp125 colocalized with p58 in discrete vesicular structures (compare Fig. 6, g and h) , similar to the colocalization of HA with p58 in Fig. 5 . This indicates that the failure to be transported beyond the p58-containing compartment is not specific to a viral glycoprotein, but also occurs with an endogenous Golgi protein, gp125.
Disappearance of the Golgi Complex in V.24.I Cells at the Restrictive Temperature
To see what effect the lesion in the mutant cells had on the morphology of the Golgi complex, mutant and wild-type cells were incubated at 41~ for 2 h and were prepared for immunofluorescence microscopy to simultaneously observe gp125 and either ribophorin II (an ER resident protein) or p58. The morphology of the ER (compare Fig. 7, b and d) was similar in the mutant and wild-type cells, as was the morphology of the intermediate compartment (compare Fig.  7 , f and h), suggesting that the structure of these two compartments was not severely affected by the lesion in the mutant cells. However, the Golgi complex, readily identified by 
(e-h)
Cells incubated with rat antigpl25 and rabbit anti-p58 primary antibodies followed by FITC-labeled donkey anti-rat IgG and Texas red-labeled mouse anti-rabbit IgG as secondary antibodies.
staining for gp125 in the wild-type cells (Fig. 7, a and e) , was hardly visible above the background in V.24.1 cells (Fig. 7,  c and g ). Within the resolution of fluorescence microscopy, it did not appear as ifgp125 had left the Golgi and distributed to either the ER or the p58-containing compartment in the mutant cells.
To verify the apparent absence of the Golgi complex in V.24.1 cells, we used a different marker, mannosidase II (another Golgi-associated integral membrane protein) (25) , and monitored the rate of the Golgi disappearance upon shifting cells to the restrictive temperature. As seen in Fig. 8 (a and   b) , the morphology of the wild-type Golgi complex stained for mannosidase II was similar to that when stained for gp125 in Fig. 7 (a and e) . In addition, the Golgi in the wildtype cells looked similar at 34 and 41~ There was also little difference between the Golgi in V.24.1 cells and wild-type cells at 34~ (Fig. 8, a and c) . However, after 15 min at the restrictive temperature the Golgi complex in V.24.1 cells appeared to fragment into vesicles that with time became smaller and more dispersed throughout the cytoplasm until by 120 min there was little visible evidence of the Golgi (Fig. 8, d-h ). The 58-kD protein did not colocalize in vesi- Figure 8 . The rate of Golgi complex disappearance in V.24.1 cells at the restrictive temperature. Cells grown on glass coverslips were incubated at 41~ for the times indicated. The cells were then fixed, permeabilized, and stained for immunofluorescence using rabbit antimannosidase II followed by rhodamine-labeled goat anti-rabbit IgG.
cles with gp125 during the fragmentation process (data not shown), evidence that Golgi proteins did not accumulate in an intermediate compartment occupied by p58 as the fragmentation process progressed. The Golgi complex was also not visible by 2 h at 41~ when stained with the fluorescent sphingolipid C6-NBD-ceramide (34) , suggesting that both Golgi proteins and Golgi lipids dispersed in the mutant cells (data not shown). Figure 9 . Golgi carbohydrate processing enzymes do not appear to return to the ER in V.24.1 cells at the restrictive temperature. Wild-type and mutant cells were infected with influenza virus at 34~ and incubated at 34~ for an additional 6 h to express HA before temperature shift (a, c, d) or the addition ofBFA (b). BFA (final concentration 5/~g/ml) was added either at 41~ (a and d), or at 34~ before the shift to 41~ (b), or not at all (c). Cells were pulsed with Tran35S-label for 5 min and chased for the times indicated. For b, 100 #tM of cycloheximide was added with BFA and was kept in the medium throughout the experiment to stop new protein synthesis except during pulse labeling. HA was immunoprecipitated, digested with endo H, electrophoresed and detected as described in Materials and Methods.
Golgi Carbohydrate-processing Enzymes Fail to Process N-linked Oligosaccharide Chains of HA in the ER of V.24.1 Cells at High Temperature
The disappearance of the Golgi complex in the mutant cells is reminiscent of the loss of the Golgi in cells caused by BFA (12-14, 24, 25, 33) . However, it did not appear that gp125 or mannosidase II were redistributing to the ER by immunofluorescence microscopy. Nevertheless, the two Golgi proteins may have been too dilute in the ER to detect. Therefore, we checked the return of Golgi carbohydrate processing enzymes to the ER by their ability to modify the N-finked oligosaccharides of HA within the ER. AS one control, we measured the capacity of BFA to induce Golgi carbohydrate-processing enzymes to return to the ER at high temperature in wild-type cells. The procedure is summarized at the left of Fig. 9 a. Cells were infected with influenza virus at 34~ and incubated for an additional 6 h to express HA, placed at 41~ treated with BFA, pulsed for 5 rain with Tran35S-label, and chased for different times. HA was immunoprecipitated and treated with endo H to see if carbohydrate processing of HA had occurred in the ER. As seen in the fight portion of Fig. 9 a, by 4 h of the chase, almost all of the HA had been processed to the endo H-resistant form, demonstrating the validity of the assay. As a second control, we added BFA to induce Golgi enzymes to return to the ER in V.24.1 cells at 34~ and then raised the temperature and assessed the effects on the endo H sensitivity of HA (Fig. 9  b) . Cycloheximide was added together with BFA and was present throughout the experiment except during pulse labeling to eliminate the possibility of HA being processed by newly synthesized Golgi carbohydrate processing enzymes retained in the ER by BFA treatment. HA became resistant to endo H by 4 h of chase, demonstrating that Golgi carbohydrate processing enzymes were not inactivated in the mutant cells simply by raising the temperature to 41~ Next, we determined whether incubating V.24.1 cells at 41~ in the absence of BFA resulted in processing of HA to endo H resistance. As shown in Fig. 9 c, HA remained sensitive to endo H, even after 6 h at 41~ strongly suggesting that the lesion in V.24.1 cells was not causing Golgi enzymes to enter the ER. Furthermore, there was no processing of HA oligosaccharides even when BFA was added to V.24.1 cells after they had been incubated at high temperature (Fig. 9 d) . Altogether, this data indicates that the effects of the lesion on the Golgi complex in the mutant cells is not identical to the effects of BFA on the Golgi.
Monensin Retards the Disappearance of the Golgi Complex
Two different kinds of mechanism could underlie the apparent disappearance of the Golgi complex in the mutant cells. One possibility is that some aspect of membrane transport between Golgi cisternae participates in dissipating Golgi membrane. Alternatively, the Golgi might somehow dissipate without need for any specific membrane transport process. If transport between Golgi cisternae is necessary for the Golgi to disappear, then inhibiting transport should result in the persistence of the Golgi at the restrictive temperature. The proton ionophore monensin, which exchanges protons for sodium across membranes, inhibits transport between cisternae of the Golgi (18, 53) . To see whether monensin had an effect on the disappearance of the Golgi complex, wild-type and V.24.1 cells were incubated at 41~ for 2 h without (Fig. 10, a and b) or with (Fig. 10, c and d ) monensin and stained with antibody to gp125. The Golgi complex was still visible in mutant cells treated with monensin, but not in the control cells in the absence of the drug. This result suggests that whatever process underlies the disappearance of the Golgi complex, membrane transport between Golgi cisternae is involved. In further experiments we extended the incubation at 41~ in the presence of monensin up to 4 h and observed that, given the additional time, the Golgi complex did eventually disappear (data not shown). Thus, monensin delays, but does not completely stop, the disappearance of the Golgi complex in V.24.1 cells.
Another activity of monensin is to raise lysosomal pH, which blocks degradation of material within lysosomes (28) . If Golgi membrane were aberrantly entering lysosomes in the mutant cells, then undegraded Golgi proteins might accumulate in lysosomes in the presence of monensin. However, we observed no accumulation of gp125 within lysosomes during prolonged treatment with the drug (data not shown). Treating cells with the lysosomotropic drug chloroquine, which also inhibits digestion in lysosomes (I1), also did not result in visible accumulation of gp125 in lysosomes (data not shown).
The Disappearance of the Golgi Complex in V.24.I Cells Is Not a Consequence of Micratubule Depolymerization
The depolymerization of rnicrotubules in intact cells causes the Golgi complex to fragment and then disperse throughout the cytoplasm (35, 40, 41, 55) . It was possible, therefore, that the fragmentation of the Golgi in the mutant cells could be Figure 11 . The role of microtubules in the disappearance of the Golgi complex in V.24.1 cells. In a and b, cells were incubated at 41~ for 2 h, fixed, and incubated with mouse antityrosinated tubulin followed by a secondary antibody of RITC-conjugated goat antimouse. In c and d, cells were incubated at 34~ with nocodazole (20/~g/ml) for 2 h and shifted to 41"C for an additional 2 h in the presence of nocodazole. The cells were stained to detect Golgi mannosidase It as in Fig. 8 .
caused by a loss in the integrity of microtubules. To investigate the possibility that microtubules were depolymerized in V.24,1 cells at the nonpermissive temperature, mutant and wild-type ceils were incubated at 41~ and stained for tubulin. The microtubular network looked the same in both cells (Fig. 11, a and b) , evidence that the lesion in V.24.1 cells was not correlated with any gross depolymerization of microtubutes. In addition, we compared the morphology of the Golgi complex in mutant and wild-type cells that were pretreated at 34~ with nocodazole to depolymerize microtubules, incubated at high temperature for 2 h with nocodazole, and then stained for mannosidase II (Fig. 11, c and d) . In wildtype cells, the Golgi complex fragmented when microtubules wore depolymerized, but the fragments were large and visible at all times. Interestingly, when microtubules were depolymerized in V.24.1 ceils before incubation at the restrictive temperature for 2 h, the Golgi complex fragmented to the extent seen in wild-type cells with nocodazole, but did not disappear as when nocodazole was absent (compare Fig.  11, d and 8 h) . Upon longer incubation at the restrictive temperature, the Golgi complex did eventually disappear (data not shown), analogous to results with monensin, indicating that nocodazole retarded, but did not completely inhibit, the loss of the GolgL The disappearance of the Golgi complex in V.24.1 cells at high temperature appears to be fundamentally different than the fragmentation of the Golgi complex in cells that have depolymerized microtubules.
Discussion
V.24.1 cells define the End4 complementation group of temperature-sensitive CHO cell mutants selected for resistance to protein toxins (7) . Previous studies indicated that the properties of mutant V.24.1 are consistent with the presence of a single and revertible genetic lesion that creates a temperature-sensitive protein (8) . We recently reported that secretion in V.24.1 cells was blocked at a step before the medial Golgi (39, 56) . In 1985, Nakano et al. (31) described a temperature-sensitive mutant of CHO cells, termed DS28-6, that had a similar secretion-defective phenotype. We have recently analyzed somatic cell hybrids made by fusing V.24.1 and DS28-6 cells and found that the hybrids have the mutant phenotype, indicating that the two mutants are in the same complementation group (Wang, R.-H., E A. Colbaugh, and R. K. Draper, unpublished work). Another mutant, termed HRP-1, independently isolated in this tab using a new selection scheme, also failed to complement the lesion in V.24.1 and DS28-6 cells (Wang, R.-H., E A. Colbaugh, and R. K. Draper, unpublished work). Thus, there are now at least three independently isolated members of the End4 complementation group.
A failure to secrete glycoproteins could be a consequence of aberrant folding or otigomerization in the ER, leading to retention of misfolded proteins. However, this does not explain the defect in End4 mutants, because HA folded and trimerized at the same rate in V.24.1 and wild-type cells at the restrictive temperature. The failure to secrete could also be related to unusual protein glycosylation, since Hearing et al. (19, 20) reported that addition of truncated N-linked oligosaccharides to HA impaired secretion in a temperaturesensitive mutant of CHO cells. However, in the present work, and in previous studies (39, 56) , we have not observed any unusual electrophoretic migration of newly synthesized glycoproteins in SDS-polyacrylamide gels that would suggest aberrant or heterogeneous oligosaccharides were present on glycoproteins. There is no evidence that the failure of End4 mutants to secrete is related to structural or conformational abnormalities of secretory proteins.
The Intermediate Compartment
Morphological (43, 44, 49) and biochemical (3, 50, 54) (44, 45) , consistent with the possibility that HA was in the intermediate compartment since it is unlikely that HA reached the cis-Golgi. Vesicles containing HA and p58 were not a collapsed form of the ER caused by the mutation in V.24.1 cells because the morphology of the ER was normal as assessed by staining for the ER proteins BiP and ribophorin II. A Golgi protein, gp125, that had been induced to return to the ER by addition of BFA at the permissive temperature, also accumulated in the p58-containing vesicles when BFA was removed at the restrictive temperature. This demonstrated that viral infection is not a factor in the accumulation of proteins between the ER and the Golgi.
The simplest interpretation of our observations is that secretion is blocked in V.24.1 cells at the level of export from the intermediate compartment defined by others. However, there are alternative possibilities. The compartment in which HA accumulates could represent a collection of transport vesicles en route from the ER to the intermediate compartment, or en route from the intermediate compartment to the Golgi. It is also possible that HA accumulates in a special subdomain of the ER, such as the transitional ER, especially if p58 were to collect in this subdomain in the mutant cells but not parental cells.
The intermediate compartment consists of vesicles and tubules that are frequently, although not always, very close to the cis-Golgi (43) (44) (45) 49) . As a result, the relationship between the cis-Golgi and the intermediate compartment has been difficult to define. When cells are treated with nocodazole to depolymerize microtubules and disperse the Golgi, the intermediate compartment appears to go with the Golgi as if they were one organelle (5, 25, 44) . However, in BFAtreated cells, the Golgi merges with the ER, but the intermediate compartment retains at least some structural identity (25, 44) , suggesting the two compartments are different. To the extent that p58 marks the intermediate compartment in the mutant cells, the lesion in End4 mutants distinguishes between the Golgi and the intermediate compartment since the Golgi complex vanishes at the restrictive temperature while the p58-containing compartment persists.
Disappearance of the Golgi Complex
The Golgi complex could not be detected by immunofluorescence microscopy in V.24.1 cells after 2 h at 41~ when stained with anti-gp125, antimannosidase II, or Ct-NBDceramide. It should be emphasized that the Golgi complex disappears at the resolution of fluorescence microscopy: ultrastructural studies are in progress and it is possible that Golgi remnants may be identified at high resolution. The absence of the Golgi agrees with the recent report of Zuber et al. (59) that the Golgi complex disappeared at high temperature in mutant DS28-6, which is in the same complementation group as mutant V.24.1. Zuber et al. (59) further reported several aspects of the disappearing Golgi in DS28-6 cells that were similar to the effects of BFA on the Golgi. (a) The redistribution of the Golgi enzymes mannosidase II and galactosyl transferase to the ER by immunofluorescence microscopy. (b) The redistribution of a Golgi lipid marker to the ER by immunofluorescence microscopy. (c) The presence of complex carbohydrates in the ER detected with lectin-gold labeling, consistent with the possibility of Golgiassociated carbohydrate-processing enzymes being returned to the ER. Our data differ regarding the analogy between BFA and the lesion in End4 mutants. While we have no ultrastructural data to indicate where the Golgi is going, we did not observe a clear accumulation of Golgi protein or lipid in the ER by immunofluorescence. This could be explained if our experiments were not sensitive enough to detect Golgi markers diluted into the ER. However, we also did not biochemically detect processing of N-linked oligosaccharides of HA in the ER by Golgi enzymes.
One explanation to account for the disappearance of the Golgi is that Golgi components might be returning to the ER as in BFA-treated cells, but in a fashion that somehow does not result in the processing of N-linked oligosaccharides by Golgi enzymes in the ER. The complex carbohydrate within the ER observed by Zuber et al. (59) using lectin-gold cytochemistry could have come from preexisting glycoproteins transported from the Golgi to the ER rather than by processing of oligosaccharide chains in the ER. However, the possibility that Golgi components are not returning to the ER cannot be dismissed and we can think of three explanations that might account for this~ First, Gotgi membrane might fragment into vesicles too small to be detected by immunofluorescence microscopy if vesicles involved in transport between Golgi cisternae formed but did not bind to or fuse with their target membranes. Conceivably, the vesicles might require microtubules to disperse throughout the cytoplasm. This mechanism is similar to that proposed to explain the fragmentation of the Golgi during mitosis (15, 26, 27) and it is possible that the Golgi undergoes premature mitotic breakdown in the mutant cells. Second, the Golgi might disappear if secretory transport out of the Golgi were to continue while compensatory replacement of secreted membrane was blocked due to the lesion. Secretion would be delayed by monensin and nocodazole, accounting for the persistence of the Golgi in the presence of the drugs. If the secretion model were correct, we might have expected in our immunofluorescence studies to have seen gp125 and mannosidase II in the plasma membrane, or possibly in vesicles of the endocytic apparatus, but we did not. However, the Golgi proteins might not have been detected if they were highly diluted in cell surface and endocytic membranes. Third, Golgi membrane might be degraded by a process that requires membrane transport and microtubules. Although we did not observe any accumulation of gp125 in lysosomes in the presence of monensin or chloroquine to inhibit lysosomal degradation, there may not have been enough gp125 in lysosomes to detect. Moreover, it is possible that degradation is by a nonlysosomal process. Further work is necessary to understand what happens to the Golgi in V.24.1 cells.
